GOCO - GoHealth Inc Stock Price, Fair Value and News

8.58USD-0.33 (-3.70%)Market Closed

Market Summary

USD8.58-0.33

Market Closed

-3.70%

GOCO Stock Price

View Fullscreen

GOCO RSI Chart

GOCO Valuation

Market Cap

83.4M

Price/Earnings (Trailing)

-1.32

Price/Sales (Trailing)

0.11

EV/EBITDA

-5.84

Price/Free Cashflow

0.82

GOCO Price/Sales (Trailing)

GOCO Profitability

Operating Margin

79.45%

EBT Margin

-20.34%

Return on Equity

-16.41%

Return on Assets

-4.54%

Free Cashflow Yield

121.38%

GOCO Fundamentals

GOCO Revenue

Revenue (TTM)

737.1M

Rev. Growth (Yr)

1.33%

Rev. Growth (Qtr)

-32.92%

GOCO Earnings

Earnings (TTM)

-63.3M

Earnings Growth (Yr)

-0.4%

Earnings Growth (Qtr)

-651.71%

Breaking Down GOCO Revenue

Last 7 days

-4.8%

Last 30 days

-13.4%

Last 90 days

-37.4%

Trailing 12 Months

-50.8%

How does GOCO drawdown profile look like?

GOCO Financial Health

Current Ratio

1.32

Debt/Equity

1.06

Debt/Cashflow

0.25

GOCO Investor Care

Shares Dilution (1Y)

8.37%

Diluted EPS (TTM)

-7.09

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	737.1M	0	0	0
2023	544.2M	528.4M	527.4M	734.7M
2022	1.1B	1.1B	1.0B	631.7M
2021	940.5M	1.0B	1.1B	1.1B
2020	568.7M	654.3M	739.9M	877.4M
2019	0	0	311.8M	483.1M
2018	0	0	0	226.2M

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of GoHealth Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
May 05, 2024	burd brad	sold (taxes)	-8,229	10.11	-814	chief legal officer
Apr 10, 2024	schulz jason	sold (taxes)	-30,192	9.6	-3,145	chief financial officer
Apr 10, 2024	kotte vijay	sold (taxes)	-156,269	9.6	-16,278	chief executive officer
Apr 01, 2024	schulz jason	acquired	-	-	33,333	chief financial officer
Apr 01, 2024	kotte vijay	acquired	-	-	166,666	chief executive officer
Apr 01, 2024	burd brad	acquired	-	-	50,000	chief legal officer
Apr 01, 2024	hargis mike	acquired	-	-	100,000	chief operating officer
Mar 21, 2024	hargis mike	sold (taxes)	-66,537	10.34	-6,435	chief operating officer
Mar 21, 2024	burd brad	sold (taxes)	-11,363	10.34	-1,099	chief legal officer
Feb 11, 2024	burd brad	sold (taxes)	-1,688	12.99	-130	chief legal officer

Which funds bought or sold GOCO recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 16, 2024	COMERICA BANK	reduced	-40.77	-925	809	-%
May 16, 2024	CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	reduced	-30.89	-4,150	4,961	-%
May 15, 2024	Tower Research Capital LLC (TRC)	reduced	-16.4	-4,499	8,681	-%
May 15, 2024	MILLENNIUM MANAGEMENT LLC	sold off	-100	-170,045	-	-%
May 15, 2024	BRIDGEWAY CAPITAL MANAGEMENT, LLC	added	7.72	-36,611	205,323	-%
May 15, 2024	Royal Bank of Canada	reduced	-91.86	-14,000	1,000	-%
May 15, 2024	ZACKS INVESTMENT MANAGEMENT	added	36.56	10,801	153,099	-%
May 15, 2024	MORGAN STANLEY	reduced	-9.51	-170,796	424,142	-%
May 15, 2024	Centerbridge Partners, L.P.	unchanged	-	-11,829,000	43,930,200	7.05%
May 15, 2024	Blue Owl Capital Holdings LP	unchanged	-	-235,641	875,120	0.17%

Are Funds Buying or Selling GOCO?

Are funds buying GOCO calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own GOCO

No. of Funds

Unveiling GoHealth Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Aug 25, 2023	nvx holdings, inc.	39.6%	6,232,352	SC 13D/A
Aug 25, 2023	centerbridge associates iii, l.p.	64.2%	9,566,028	SC 13D/A
May 19, 2023	nvx holdings, inc.	40.8%	6,232,352	SC 13D/A
May 19, 2023	centerbridge associates iii, l.p.	66.3%	9,566,028	SC 13D/A
Feb 14, 2023	harris associates l p	0.0%	0	SC 13G/A
Feb 09, 2023	vanguard group inc	1.98%	176,102	SC 13G/A
Dec 12, 2022	ccp iii cayman gp ltd.	66.3%	9,459,897	SC 13D/A
Dec 02, 2022	ccp iii cayman gp ltd.	64.5%	9,213,506	SC 13D/A
Nov 25, 2022	nvx holdings, inc.	42.2%	6,232,352	SC 13D
Nov 25, 2022	ccp iii cayman gp ltd.	62.3%	8,897,947	SC 13D

Recent SEC filings of GoHealth Inc

View All Filings

Date Filed	Form Type	Document
May 09, 2024	10-Q	Quarterly Report
May 09, 2024	8-K	Current Report
May 07, 2024	4	Insider Trading
Apr 26, 2024	DEF 14A	DEF 14A
Apr 26, 2024	DEFA14A	DEFA14A
Apr 12, 2024	4	Insider Trading
Apr 12, 2024	4	Insider Trading
Apr 03, 2024	4	Insider Trading
Apr 03, 2024	4	Insider Trading
Apr 03, 2024	4	Insider Trading

Peers (Alternatives to GoHealth Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
ARGO	1.1T	1.3B	1.56%	3220.84%	-5.4K	851.43	-10.27%	-34.69%
AJG	56.3B	10.6B	11.80%	20.14%	51.57	5.3	20.42%	-6.05%
AIG	53.5B	48.4B	11.01%	48.35%	11.07	1.1	-4.15%	-20.63%
TRV	50.3B	42.9B	6.36%	19.84%	16.03	1.17	13.52%	12.15%
AFL	50.2B	19.3B	10.10%	32.07%	9.39	2.6	3.03%	17.35%
ACGL	37.9B	14.4B	11.43%	34.12%	7.82	2.63	32.92%	143.01%
AFG	11.2B	8.0B	7.21%	13.44%	12.7	1.4	11.14%	7.56%
MID-CAP
UNM	10.1B	12.6B	5.84%	14.37%	7.61	0.8	4.24%	-13.40%
AIZ	9.1B	11.4B	3.23%	33.23%	11.93	0.8	9.81%	217.29%
LNC	5.1B	11.9B	12.70%	41.34%	3.81	0.43	-33.27%	234.43%
AEL	3.9B	3.2B	-0.20%	45.14%	5.55	1.23	64.05%	-35.60%
SMALL-CAP
BRP	2.0B	1.3B	23.61%	49.66%	-37.13	1.59	18.74%	30.90%
AMSF	887.3M	308.9M	-4.69%	-15.41%	14.38	2.87	3.79%	10.94%
AMBC	818.6M	314.0M	28.73%	23.89%	14.24	2.61	-29.20%	-88.19%
AAME	35.5M	187.5M	-11.22%	-20.55%	-49.09	0.19	2.74%	73.83%

GoHealth Inc News

Latest updates

GoHealth Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

Income Statement (Quarterly)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q3	2018Q4
Revenue	-32.9%	185,600,000	276,697,000	132,037,000	142,779,000	183,158,000	69,376,000	133,052,000	158,654,000	270,593,000	449,600,000	211,734,000	196,902,000	204,179,000	445,923,000	163,360,000	127,057,000	141,010,000	308,491,000	197,950,500	87,410,000	-
Cost Of Revenue	-7.5%	38,013,000	41,085,000	35,992,000	36,422,000	45,462,000	20,629,000	48,044,000	51,074,000	67,923,000	99,886,000	53,632,000	37,442,000	48,375,000	94,682,000	25,827,000	36,559,000	42,134,000	90,384,000	-	25,055,000	-
Costs and Expenses	-27.5%	189,632,000	261,637,000	170,013,000	195,795,000	188,907,000	202,554,000	192,191,000	259,695,000	295,901,000	872,754,000	260,440,000	215,899,000	202,769,000	304,092,000	361,156,000	141,465,000	135,183,000	284,393,000	-	164,730,000	-
S&GA Expenses	-100.0%	-	19,629,000	12,967,000	37,855,000	22,618,000	24,633,500	25,611,000	38,106,000	29,217,000	28,906,000	24,295,000	25,297,000	19,685,000	19,828,500	156,551,000	10,359,000	10,491,000	13,674,000	-	65,123,000	-
EBITDA Margin	3.5%	-0.09	-0.10	-0.42	-0.45	-0.52	-0.48	-0.58	-0.53	-0.45	-0.46	0.07	-0.08	-0.07	-0.07	-0.24	0.05	0.06	0.07	0.09	0.11	0.15
Interest Expenses	1.1%	17,951,000	17,751,000	17,565,000	17,265,000	16,891,000	17,317,000	15,630,000	12,724,000	11,398,000	9,619,000	6,921,000	8,277,000	8,688,000	8,591,000	8,636,000	8,986,000	6,756,000	8,076,000	-	31,000	-
Income Taxes	-118.7%	-71,000	379,000	-108,000	-73,000	-44,000	292,000	-	-	472,000	118,000	-79,000	-32,000	-31,000	5,000	62,000	-22,000	-2,000	44,000	-	-78,000	-
Earnings Before Taxes	-1018.4%	-21,417,000	-1,915,000	-56,312,000	-70,302,000	-22,587,000	-150,445,000	-74,654,000	-113,752,000	-36,769,000	-432,077,000	-55,597,000	-39,253,000	-7,291,000	133,104,500	-206,434,000	-22,889,000	-939,000	16,039,000	-	-77,418,000	-
EBT Margin	1.1%	-0.20	-0.21	-0.57	-0.60	-0.66	-0.59	-0.65	-0.59	-0.50	-0.50	0.03	-0.12	-0.11	-0.11	-0.29	0.04	0.05	0.06	0.07	0.09	0.12
Net Income	-651.7%	-9,216,000	-1,226,000	-23,910,000	-28,942,000	-9,179,000	-61,399,000	-30,005,000	-43,819,000	-13,483,000	-155,026,000	-20,240,000	-12,004,000	-2,087,000	35,956,500	-56,420,000	-22,867,000	-937,000	15,995,000	-	-77,340,000	-
Net Income Margin	0.3%	-0.09	-0.09	-0.23	-0.25	-0.27	-0.24	-0.24	-0.21	-0.18	-0.18	0.00	-0.03	-0.05	-0.05	-0.09	-0.15	-0.17	-0.20	0.07	0.09	0.12
Free Cashflow	-82.5%	12,512,000	71,301,000	6,500,000	10,861,000	20,479,000	-40,999,000	95,526,000	-48,109,000	54,486,000	-226,587,000	-40,169,000	-63,452,000	31,202,000	-143,052,000	33,004,000	-27,756,000	23,587,000	-9,284,000	-3,698,000	-3,698,000	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2019Q4
Assets	-7.0%	1,395	1,500	1,437	1,482	1,543	1,659	2,002	1,898	1,963	2,069	2,131	2,112	2,098	2,109	1,938	1,602
Current Assets	-16.7%	397	476	346	368	375	415	468	333	392	429	257	296	321	392	417	144
Cash Equivalents	7.7%	98.00	91.00	26.00	25.00	32.00	16.00	215	76.00	130	84.00	85.00	113	174	144	295	12.00
Net PPE	-	-	-	-	-	-	-	-	-	-	-	27.00	24.00	21.00	17.00	15.00	6.00
Goodwill	-	-	-	-	-	-	-	-	-	-	-	387	387	387	387	387	387
Current Liabilities	-18.9%	300	370	218	210	210	265	255	142	141	217	133	114	100	127	145	113
Long Term Debt	-2.9%	410	423	497	496	490	505	660	662	663	665	439	415	396	396	397	288
LT Debt, Current	0%	75.00	75.00	-	-	19.00	5.00	5.00	5.00	5.00	5.00	4.00	4.00	4.00	4.00	4.00	3.00
LT Debt, Non Current	-100.0%	-	423	497	496	490	505	660	662	663	665	439	415	396	396	397	288
Shareholder's Equity	66.9%	386	231	228	461	523	269	689	758	860	892	1,317	1,365	1,396	1,399	1,263	860
Retained Earnings	-2.2%	-429	-420	-419	-395	-366	-357	-295	-265	-221	-208	-53.06	-32.88	-20.89	-18.80	-54.76	-
Additional Paid-In Capital	0.8%	659	654	649	646	630	626	621	613	583	561	550	504	466	399	392	-
Shares Outstanding	4.6%	10.00	9.00	9.00	9.00	9.00	8.00	8.00	8.00	8.00	7.00	8.00	6.00	6.00	6.00	6.00	-
Minority Interest	-8.5%	160	175	177	211	260	274	364	412	499	539	820	895	952	1,019	925	-
Float	-	-	-	-	88.00	-	-	-	49.00	-	-	-	725	-	-	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q3	2019Q2
Cashflow From Operations	-82.5%	12,512	71,301	6,500	10,861	20,479	-40,999	95,526	-48,109	54,486	-226,587	-40,169	-63,452	31,202	-143,052	33,004	-27,756	23,587	-9,284	-	-3,698	-
Share Based Compensation	-58.1%	1,783	4,251	2,173	8,681	4,444	4,366	5,483	12,138	5,155	7,197	7,389	7,599	5,112	3,083	212,070	597	479	448	-	-	-
Cashflow From Investing	19.3%	-4,556	-5,645	-3,427	-2,434	-2,226	-1,416	-2,438	-3,661	-5,997	-532	-11,360	-4,169	-3,740	-2,500	-4,259	-4,242	-3,522	-810,010	-	-814	-
Cashflow From Financing	13.3%	-942	-1,087	-2,193	-15,429	-2,397	-156,591	46,003	-1,358	-3,105	226,346	23,855	6,612	2,276	-4,915	147,678	-2,267	120,167	830,879	-	1,407	-

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

GOCO Income Statement

2024-03-31

Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Net revenues	$ 185,600	$ 183,158
Operating expenses:
Revenue share	38,013	45,462
Marketing and advertising	52,775	45,743
Consumer care and enrollment	47,861	42,027
Technology	10,550	9,543
General and administrative	16,919	22,618
Amortization of intangible assets	23,514	23,514
Total operating expenses	189,632	188,907
Income (loss) from operations	(4,032)	(5,749)
Interest expense	17,951	16,891
Other (income) expense, net	(566)	(53)
Income (loss) before income taxes	(21,417)	(22,587)
Income tax (benefit) expense	(71)	(44)
Net income (loss)	(21,346)	(22,543)
Net income (loss) attributable to non-controlling interests	(12,130)	(13,364)
Net income (loss) attributable to GoHealth, Inc.	$ (9,216)	$ (9,179)
Net loss per share (Note 7):
Net income (loss) per share of Class A common stock — basic (in dollars per share)	$ (1.04)	$ (1.12)
Net income (loss) per share of Class A common stock — diluted (in dollars per share)	$ (1.04)	$ (1.12)
Weighted-average shares of Class A common stock outstanding — basic (in shares)	9,715	8,965
Weighted-average shares of Class A common stock outstanding — diluted (in shares)	9,715	8,965

GOCO Balance Sheet

2024-03-31

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 97,818	$ 90,809
Accounts receivable, net of allowance for doubtful accounts of $6 in 2024 and $27 in 2023	9,226	250
Commissions receivable - current	269,799	336,215
Prepaid expense and other current assets	20,254	49,166
Total current assets	397,097	476,440
Commissions receivable - non-current	573,328	575,482
Operating lease ROU asset	21,008	21,995
Other long-term assets	2,118	2,256
Property, equipment, and capitalized software, net	28,667	26,843
Intangible assets, net	373,040	396,554
Total assets	1,395,258	1,499,570
Current liabilities:
Accounts payable	5,773	17,705
Accrued liabilities	66,595	86,254
Commissions payable - current	94,896	118,732
Short-term operating lease liability	5,309	5,797
Deferred revenue	38,723	52,403
Current portion of long-term debt	75,000	75,000
Other current liabilities	13,707	14,122
Total current liabilities	300,003	370,013
Non-current liabilities:
Commissions payable - non-current	201,653	203,255
Long-term operating lease liability	38,198	39,547
Long-term debt, net of current portion	410,324	422,705
Other non-current liabilities	9,247	9,095
Total non-current liabilities	659,422	674,602
Commitments and Contingencies (Note 11)
Stockholders’ equity:
Preferred stock	0	0
Additional paid-in capital	659,080	654,059
Accumulated other comprehensive income (loss)	(129)	(127)
Accumulated deficit	(429,496)	(420,280)
Total stockholders’ equity attributable to GoHealth, Inc.	225,875	231,014
Non-controlling interests	159,765	174,639
Total stockholders’ equity	385,640	405,653
Total liabilities, redeemable convertible preferred stock and stockholders’ equity	1,395,258	1,499,570
Series A Convertible Preferred Stock
Non-current liabilities:
Series A redeemable convertible preferred stock — $0.0000 par value; 50 shares authorized; 50 shares issued and outstanding as of both March 31, 2024 and December 31, 2023. Liquidation preference of $51.9 million and $50.9 million as of March 31, 2024 and December 31, 2023, respectively.	50,193	49,302
Class A Common Stock
Stockholders’ equity:
Common stock	1	1
Treasury stock – at cost; 262 and 173 shares of Class A common stock as of March 31, 2024 and December 31, 2023, respectively.	(3,582)	(2,640)
Class B Common Stock
Stockholders’ equity:
Common stock	1	1
Series A-1 Convertible Preferred Stock
Stockholders’ equity:
Preferred stock	$ 0	$ 0

About GoHealth Inc

GoHealth, Inc. operates as a health insurance marketplace and Medicare focused digital health company in the United States. It operates through four segments: MedicareÃ‚â€”Internal; MedicareÃ‚â€”External; Individual and Family Plans (IFP) and OtherÃ‚â€”Internal; and IFP and OtherÃ‚â€”External. The company operates a technology platform that leverages machine-learning algorithms of insurance behavioral data to optimize the process for helping individuals find the health insurance plan for their specific needs. Its products include Medicare Advantage, Medicare Supplement, Medicare prescription drug plans, and Medicare Special Needs Plans; and IFP, dental plans, vision plans, and other ancillary plans to individuals. The company sells its products through carriers and online platform, as well as independent and external agencies. GoHealth, Inc. was founded in 2001 and is headquartered in Chicago, Illinois.

CEO	Mr. Vijay Kumar Kotte
WEBSITE	gohealth.com
INDUSTRY	Insurance Property & Casualty
EMPLOYEES	2467

GoHealth Inc Frequently Asked Questions

What is the ticker symbol for GoHealth Inc? What does GOCO stand for in stocks?

GOCO is the stock ticker symbol of GoHealth Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of GoHealth Inc (GOCO)?

As of Fri May 17 2024, market cap of GoHealth Inc is 83.35 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of GOCO stock?

You can check GOCO's fair value in chart for subscribers.

What is the fair value of GOCO stock?

You can check GOCO's fair value in chart for subscribers. The fair value of GoHealth Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of GoHealth Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for GOCO so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is GoHealth Inc a good stock to buy?

The fair value guage provides a quick view whether GOCO is over valued or under valued. Whether GoHealth Inc is cheap or expensive depends on the assumptions which impact GoHealth Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for GOCO.

What is GoHealth Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri May 17 2024, GOCO's PE ratio (Price to Earnings) is -1.32 and Price to Sales (PS) ratio is 0.11. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. GOCO PE ratio will change depending on the future growth rate expectations of investors.